1. Home
  2. NQP vs ESPR Comparison

NQP vs ESPR Comparison

Compare NQP & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NQP
  • ESPR
  • Stock Information
  • Founded
  • NQP 1990
  • ESPR 2008
  • Country
  • NQP United States
  • ESPR United States
  • Employees
  • NQP N/A
  • ESPR N/A
  • Industry
  • NQP Trusts Except Educational Religious and Charitable
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • NQP Finance
  • ESPR Health Care
  • Exchange
  • NQP Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • NQP 438.1M
  • ESPR 399.0M
  • IPO Year
  • NQP N/A
  • ESPR 2013
  • Fundamental
  • Price
  • NQP $11.57
  • ESPR $2.46
  • Analyst Decision
  • NQP
  • ESPR Buy
  • Analyst Count
  • NQP 0
  • ESPR 4
  • Target Price
  • NQP N/A
  • ESPR $8.13
  • AVG Volume (30 Days)
  • NQP 58.4K
  • ESPR 8.7M
  • Earning Date
  • NQP 01-01-0001
  • ESPR 11-07-2024
  • Dividend Yield
  • NQP 3.21%
  • ESPR N/A
  • EPS Growth
  • NQP N/A
  • ESPR N/A
  • EPS
  • NQP N/A
  • ESPR N/A
  • Revenue
  • NQP N/A
  • ESPR $295,451,000.00
  • Revenue This Year
  • NQP N/A
  • ESPR $186.90
  • Revenue Next Year
  • NQP N/A
  • ESPR $31.10
  • P/E Ratio
  • NQP N/A
  • ESPR N/A
  • Revenue Growth
  • NQP N/A
  • ESPR 187.12
  • 52 Week Low
  • NQP $9.65
  • ESPR $1.58
  • 52 Week High
  • NQP $11.89
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • NQP 29.23
  • ESPR 46.20
  • Support Level
  • NQP $12.00
  • ESPR $1.84
  • Resistance Level
  • NQP $12.11
  • ESPR $3.94
  • Average True Range (ATR)
  • NQP 0.09
  • ESPR 0.43
  • MACD
  • NQP -0.04
  • ESPR -0.12
  • Stochastic Oscillator
  • NQP 4.31
  • ESPR 29.52

About NQP Nuveen Pennsylvania Quality Municipal Income Fund

Nuveen Pennsylvania Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal and Pennsylvania income taxes and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal, Pennsylvania state and local income taxes. It invests a majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: